CVE-2026-108798
CVSS v3
7.3
HIGH
EPSS Score
—
exploit probability
CISA KEV
No
known exploited
Exploitation
—
SSVC status
Get an alert for each new CVE published for ZKTeco BioTime. Watch ZKTeco BioTime in CVE Watch Free account · no credit card
Affected and fixed versions
Neither OSV.dev nor the vendor advisories we read list affected versions for CVE-2026-108798 yet.
Description
A vulnerability was found in ZKTeco BioTime 9.5.6 Build 20260130.3206. This issue affects some unknown processing. The manipulation results in use of hard-coded cryptographic key . The attack may be launched remotely. The vendor was contacted early about this disclosure but did not respond in any way.
Technical details
- CVSS v3 Vector
- CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
- Published
- 2026-10-12
- Last Modified
- 2026-10-12
Frequently asked questions
What is CVE-2026-108798?
A vulnerability was found in ZKTeco BioTime 9.5.6 Build 20260130.3206. This issue affects some unknown processing. The manipulation results in use of hard-coded cryptographic key . The attack may be launched remotely. The vendor was contacted early about this disclosure but did not respond in any way.
Is CVE-2026-108798 actively exploited?
Active exploitation of CVE-2026-108798 has not been confirmed.
What is the CVSS score for CVE-2026-108798?
CVE-2026-108798 has a CVSS v3 base score of 7.3 (HIGH severity), with vector string CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L.
Running ZKTeco BioTime? Hear about its next vulnerability
CVE Watch matches each new CVE to the vendors and products you list (vendor and product, not the version) and puts it in your alerts with its KEV and EPSS status.
Already have an account? Open CVE Watch
No credit card required · 50 free checks/month · Free API key
Go further
- Following what attackers exploit right now? The CISA KEV additions of the month, with their patch deadlines.
- Running this software? CVE Watch alerts you to new vulnerabilities in your products.
Related vulnerabilities
Same product first, then the same vendor advisory and the same publication week.